SINOPHARM GROUP CO. LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of 1099 for the last semiannual is 319.37 B HKD, and it's 6.17% lower compared to the previous semiannual. The net income of H2 23 is 5.35 B HKD.